ORIZURU THERAPEUTICSのトップページ
Investors 1
| Date | Name | Website |
| 22.09.2024 | T1D Fund | t1dfund.or... |
Mentions in press and media 2
| Date | Title | Description |
| 24.08.2023 | PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor | TOKYO, Aug. 24, 2023 /PRNewswire/ -- PeptiGrowth Inc (PeptiGrowth), a Japanese biotechnology company focusing on the development of synthetic peptide based growth factors and Orizuru Therapeutics, Inc(OZTx), a Japanese biopharmaceutical com... |
| 10.08.2021 | Orizuru Therapeutics Launches Operations as Research and Development-driven Company for Products Including induced Pluripotent Stem Cell (iPSC) Regenerative Medicine | Contributing to society and patients through the utilization of iPSC technology developed in Japan New company to advance two successful outcomes from T-CiRA collaboration for severe heart failure and type I diabetes to clinical application... |